Video | September 3, 2025

Rethinking CRO Deposits: Russell's Alternative To Frozen Capital

Source: Clinical Leader

Instead of handing CROs a hefty security deposit — often $500K to $1M locked away for years — Russell Hayward negotiated milestone-based payments. He warns that traditional deposits tie up capital, can’t be expensed, and deliver no return, making them a major risk for small biotechs.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader